The paper (Brodska & Makarenko, Medicine Today and Tomorrow 94(2), 2025) is a descriptive sociological questionnaire study of 200 Ukrainian women aged 48-72 (174 in menopause), surveyed autumn-winter 2024-2025. Key reported values: 84.0% awareness of menopausal mineral deficiency; 82.0% taking calcium + vitamin D3 for prevention, of whom roughly one in four bought products in supermarkets without reading instructions; 51.5% relying on physician visits or doctor-blogger videos; only 15.0% aware of bone-mineralization blood tests, and just 2.0% had testing followed by physician-guided medication; ~66.0% only partially/episodically included calcium-rich foods despite awareness. Brand-level data: Calcium-D3 Nycomed chosen by 76%, Calcemin Advance 12%, Calcyker 5%, calcium gluconate and Osteokea 2% each, chelated calcium 1%
Self-report without verification. Menopause status, medication use, and purchase locations were all self-reported; no pharmacy records, doses, or duration were verified
Sampling weakness. No sampling frame or recruitment setting is described; the two-group design (<5 vs >5 years since last menstruation) is defined but no between-group results are ever reported β a structural oddity suggesting post-hoc group creation was never used analytically.
Clinical context the survey omits. The discussion is rich, but the data cannot speak to whether supplementation was appropriate. A Cochrane review found vitamin D alone unlikely to prevent fractures (hip fracture RR 1.15, 95% CI 0.99-1.33) while vitamin D with calcium reduced hip fracture risk mainly in institutionalized older adults (RR 0.84, 95% CI 0.73-0.96), with hypercalcemia RR 2.35 vs placebo β so unsupervised supplementation is not risk-free And elevated calcium intake concerns about cardiovascular risk noted in Brazilian guidance are cited by the authors themselves
Relative to the conceptually similar Palmerston North knowledge survey (which used a validated instrument, the OKT, and statistical testing: p=0.002 and p=0.010 for group differences), this paper uses an unvalidated bespoke questionnaire and explicitly reports "statistical hypotheses were not tested" Percentages are given without confidence intervals; with N=200, a 2.0% figure represents only 4 women, so any inference from it is fragile. The "84% awareness" claim is also internally in tension with the authors' own discussion stating only every third woman knew food benefits well β different questions, but the abstract-level framing risks overstating knowledge. Internal inconsistency: the abstract states 15.0% believed balanced diet corrects mineral loss, while the results text frames this differently; imprecise denominators (82% of 200 vs 82% of the 174 menopausal subgroup) are never clarified.
The paper's most defensible contribution is documenting the supermarket-purchase/never-read-instructions behavior (~25% of supplement users) and the 41-fold gap between supplementation (82%) and testing-guided use (2%). This pattern is plausible and consistent with the knowledge-practice gap literature, but the conclusion that "high uncontrolled self-medication" exists rests entirely on self-report in an unknown sample. What would change this conclusion: pharmacy-purchase audits or linked laboratory data showing most calcium+D3 users had prescriptions and monitoring.
A modest, locally useful descriptive snapshot with genuine public-health relevance for wartime Ukraine's health-information landscape, but weak methodology: no validated instrument, no inferential statistics, no sampling design, no dose or BMD data, and numerator-level fragility at low percentages. Its claims should be treated as hypothesis-generating, not as prevalence estimates. Confidence: moderate for the direction of findings; low for exact percentages.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.